Co-Development Partnerships

About Tricol Biomedical

Tricol Biomedical is a private, commercial-stage medical device company focused on hemostasis and wound care. Its core technology is a proprietary chitosan derivative called Chito+, which provides a polycationic charge to rapidly control bleeding. The company markets a portfolio of products across three segments: Trauma Management, Procedural Care, and Consumer Care, stemming from its original battlefield collaboration with the U.S. Army. Tricol operates a fully integrated model, from R&D to commercialization, and partners with other device companies.

Therapeutic Areas